Clinical trial
PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on…
NCT00296803 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00296803 |
|---|---|
| Title | PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome |
| Official title | PROCLAIM: Pilot Study Examining Effects of Clopidogrel Compared to Placebo on Markers of Inflammation in Subjects With Metabolic Syndrome |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome x |
| Intervention type | Drug |
| Interventions | clopidogrel |
| Enrollment | 216 |
| Start date | Nov 1, 2005 |
| Completion | Aug 1, 2006 |
| First posted | Feb 27, 2006 |
| Last update posted | Jan 11, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: